Nordson Medical and Fluid Solutions — EBITDA increased by 12.8% to $79.19M in Q1 2026 compared to the prior quarter. Year-over-year, this metric grew by 3.5%, from $76.54M to $79.19M. This is a positive signal — higher values indicate stronger performance for this metric.
Higher EBITDA indicates stronger operational performance and cash flow generation potential for the segment.
Earnings before interest, taxes, depreciation, and amortization for the Medical and Fluid Solutions segment, providing a...
The standard benchmark for segment-level operational performance across the industrial and medical technology sectors.
ndsn_segment_medical_and_fluid_solutions_ebitda| Q1 '23 | Q2 '23 | Q3 '23 | Q4 '23 | Q1 '24 | Q2 '24 | Q3 '24 | Q4 '24 | Q1 '25 | Q2 '25 | Q1 '26 | Q2 '26 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Value | $61.46M | $61.46M | $61.46M | $61.46M | $64.14M | $64.14M | $64.14M | $64.14M | $64.33M | $76.54M | $70.21M | $79.19M |
| QoQ Change | — | +0.0% | +0.0% | +0.0% | +4.4% | +0.0% | +0.0% | +0.0% | +0.3% | +19.0% | -8.3% | +12.8% |
| YoY Change | — | — | — | — | +4.4% | +4.4% | +4.4% | +4.4% | +0.3% | +19.3% | +9.1% | +3.5% |